Urvashi Khurana

Ms. Urvashi Khurana

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RFRym El Fessi
Rym El Fessi
RARahma Ben Abderrazek
Rahma Ben Abderrazek
UKUrvashi Khurana
Urvashi Khurana
TPThierry Pourcher
Thierry Pourcher
RKRiadh Kharrat
Riadh Kharrat
Riadh MarrouchiRiadh Marrouchi
Riadh Marrouchi
Scorpion venoms represent complex pharmacological arsenals whose complete molecular inventory remains incompletely defined, particularly for North African buthid species of high medical relevance. Buthus tunetanus is among the most clinically significant scorpion species across the Maghreb. We analysed the toxic fraction BotG50, isolated by Sephadex G-50 gel-filtration, using nanoLC-HRMS/MS coupled with an evidence-tiered, five-stage bioinformatics workflow. The workflow combines Proteome Discoverer database searching, BLAST-guided homology expansion, Casanovo de novo sequencing with variant construction, signal-peptide and propeptide removal, and post-translational modification (PTM) annotation. The analysis revealed 64 components (FDR < 1%), comprising 38 multi-peptide-supported identifications (≥2 peptides) and 26 single-peptide hits, with a median sequence coverage of 33%. The dominant neurotoxic repertoire includes toxins targeting K+, Na+, and Cl- channels, α/β toxins, insect- or mammal-specific neurotoxins, and putative depressant toxins, while a minor accessory compartment comprises hyaluronidase, phospholipase A2, lipolytic peptides, and hemocyanin-like proteins. BLAST analysis revealed strong sequence homologies with peptides from Buthus israelis (32.8%), B. tunetanus (15.6%), and Mesobuthus eupeus (10.9%). Approximately 52% of final identifications (33/64 proteins) required analytical stages beyond classical FASTA database searching. This proteomic atlas provides the most detailed molecular map of BotG50 to date, constituting a critical resource for antivenom epitope design, nanobody target selection, and bioactive peptide discovery.